Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial ischemia/reperfusion
Insufficiency in coronary blood supply results in myocardial ischemia and consequently, various clinical syndromes and irreversible injuries. Myocardial damage occurs as a result of two processes during acute myocardial infarction (MI): ischemia and subsequent reperfusion. According to the available...
Main Authors: | Sina Mahdiani, Navid Omidkhoda, Ramin Rezaee, Shadi Heidari, Gholamreza Karimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222011404 |
Similar Items
-
Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
by: Nancy Schanze, et al.
Published: (2019-06-01) -
Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2
by: Defang Li, et al.
Published: (2018-01-01) -
STAT3 but Not STAT5 Contributes to the Protective Effect of Electroacupuncture Against Myocardial Ischemia/Reperfusion Injury in Mice
by: Hui-Hui Guo, et al.
Published: (2021-07-01) -
Fructose 1,6-diphosphate alleviates myocardial ischemia reperfusion injury in rats through JAK2/STAT3 pathway
by: Ju-Fei Wang, et al.
Published: (2018-01-01) -
Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia–reperfusion-induced kidney injury via the JAK/STAT pathway
by: Xiaoying Zhao, et al.
Published: (2020-07-01)